S. Woodhead

发表

Is a Potent and Oral Inhibitor of AKT and p 70 S 6 Kinase That Induces Pharmacodynamic Changes and Inhibits Human Tumor Xenograft Growth

P. Workman, M. Walton, M. Garrett, 2010 .

AT7867 Is a Potent and Oral Inhibitor of AKT and p70 S6 Kinase That Induces Pharmacodynamic Changes and Inhibits Human Tumor Xenograft Growth

P. Workman, M. Walton, M. Garrett, 2010, Molecular Cancer Therapeutics.

Identification of novel p38alpha MAP kinase inhibitors using fragment-based lead generation.

Christopher W Murray, Alessandro Padova, Jayne Curry, 2005, Journal of medicinal chemistry.

Cancer Therapy : Preclinical AT 13148 Is a Novel , Oral Multi-AGC Kinase Inhibitor with Potent Pharmacodynamic and Antitumor Activity

P. Jones, P. Workman, M. Walton, 2012 .

AT13148 Is a Novel, Oral Multi-AGC Kinase Inhibitor with Potent Pharmacodynamic and Antitumor Activity

P. Jones, P. Workman, M. Walton, 2012, Clinical Cancer Research.

Celastraceae sesquiterpenoids: biological activity and synthesis.

S. Woodhead, M. Weston, A. Spivey, 2002, Chemical Society reviews.

Chapter 2. Synthetic methods. Part (v) Protecting groups

S. Woodhead, A. Spivey, 1998 .

Identification of inhibitors of protein kinase B using fragment-based lead discovery.

Marcel L Verdonk, Paul G Wyatt, Michelle D Garrett, 2007, Journal of medicinal chemistry.

Enantioselective Desymmetrization of meso-Decalin Diallylic Alcohols by a New Zr-Based Sharpless AE Process: A Novel Approach to the Asymmetric Synthesis of Polyhydroxylated Celastraceae Sesquiterpene Cores AE=Asymmetric epoxidation. Grateful acknowledgement is made to the EPSRC for a QUOTA students

S. Woodhead, M. Weston, A. Spivey, 2001, Angewandte Chemie.

Celastraceae Sesquiterpenoids: Biological Activity and Synthesis

S. Woodhead, M. Weston, A. Spivey, 2002 .

Towards the enantioselective synthesis of (-)-euonyminol--preparation of a fully functionalised lower-rim model.

S. Woodhead, M. Webber, A. White, 2013, Organic & biomolecular chemistry.

A total synthesis of estrone based on a novel cascade of radical cyclizations.

S. Woodhead, G. Pattenden, Miguel A. González, 2004, Proceedings of the National Academy of Sciences of the United States of America.

A structural comparison of inhibitor binding to PKB, PKA and PKA-PKB chimera.

Ian Collins, Paul Workman, Brent Graham, 2007, Journal of molecular biology.

Structure-based design of isoquinoline-5-sulfonamide inhibitors of protein kinase B.

Ian Collins, Paul Workman, Edward McDonald, 2006, Bioorganic & medicinal chemistry.

AT13148 Is a Novel, Oral Multi-AGC Kinase Inhibitor with Potent Pharmacodynamic and Antitumor Activity

P. Jones, P. Workman, M. Walton, 2012, Clinical Cancer Research.